Literature DB >> 22670505

In-hospital mortality of intermittent vs daily antitubercular regimen in patients with meningeal tuberculosis--a retrospective study.

Thomas Iype1, Litta Elizabeth George, Ajith Cherian, Aswini Kumar, B K Ajitha, Sinchu Chandy, K Vijaya Kumar.   

Abstract

INTRODUCTION: The Revised National Tuberculosis Control Programme (RNTCP), the State-run Tuberculosis Control Initiative of the Government of India, recommends intermittent thrice a week Directly Observed Treatment Short course (DOTS) both during intensive phase and continuation phase for a total of nine months for tubercular meningitis. However, most recent guidelines recommend daily regimen.
OBJECTIVE: Assessment of the in-hospital mortality in patients with meningeal tuberculosis.
MATERIAL AND METHODS: We retrospectively analyzed the data of patients (n = 98) admitted with a diagnosis of meningeal tuberculosis from January 1st 2006 to December 31st 2009 in a tertiary care centre in South India. Thwaites index score of four or less was used for diagnosis of meningeal tuberculosis which is a weighted diagnostic index score for dichotomised clinical variables including age, blood white cell count, duration of illness, CSF total white cell count, and CSF neutrophil percentage. We compared in-hospital treatment outcome of patients on thrice weekly intermittent DOTS regimen with daily regimen patients.
RESULTS: The inhospital mortality was same (27%) in the two treatment regimens (p 0.944). However, there was less incidence of hepatic dysfunction in the intermittent DOTS regimen, even though it was not statistically significant (p 0.148).
CONCLUSIONS: In the short-term, both regimens have similar mortality outcomes and no statistically significant difference in hepatic dysfunction during the hospital stay.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670505

Source DB:  PubMed          Journal:  Indian J Tuberc        ISSN: 0019-5707


  5 in total

1.  Early Mortality among Immunocompetent Patients of Tuberculous Meningitis: A Prospective Study.

Authors:  Ravi Shekhar Jaipuriar; Ravindra Kumar Garg; Imran Rizvi; Hardeep Singh Malhotra; Neeraj Kumar; Amita Jain; Rajesh Verma; Praveen Kumar Sharma; Shweta Pandey; Ravi Uniyal
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

Review 2.  Neurotuberculosis: an update.

Authors:  Ajith Cherian; Kesi Chellappan Ajitha; Thomas Iype; K P Divya
Journal:  Acta Neurol Belg       Date:  2021-01-05       Impact factor: 2.396

3.  Tuberculous meningitis on directly observed thrice a week regime.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

4.  Major outcomes of patients with tuberculous meningitis on directly observed thrice a week regime.

Authors:  Thomas Iype; Ayyappan Kunjukrishna Pillai; Ajith Cherian; Zinia T Nujum; Chithra Pushpa; Dalus Dae; Vijayakumar Krishnapillai
Journal:  Ann Indian Acad Neurol       Date:  2014-07       Impact factor: 1.383

5.  Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key.

Authors:  Anurag Bhargava; Madhavi Bhargava
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.